| Identification | More | [Name]
3-ALLYLOXY-1,2-PROPANEDIOL | [CAS]
123-34-2 | [Synonyms]
1-GLYCERYL ALLYL ETHER
3-(2-PROPENYLOXY)-1,2-PROPANEDIOL
3-ALLYLOXY-1,2-PROPANEDIOL
ALLYL 2,3-DIHYDROXYPROPYL ETHER
ALLYL ALPHA-GLYCERYL ETHER
GAE
GLYCERINE-1-ALLYL ETHER
GLYCEROL-1-ALLYL ETHER
GLYCEROL ALPHA-MONOALLYL ETHER
GLYCEROL MONO ALLYL ETHER
1-(prop-2-enyloxy)-propane-2,3-diol
1,2-Propanediol, 3-(2-propenyloxy)-
1,2-Propanediol, 3-(allyloxy)-
1-Allyloxy-2,3-propanediol
2-Propanediol,3-(2-propenyloxy)-1
3-(2-propenyloxy)-2-propanediol
3-(Allyloxy)propanediol
3-allyloxy-2-propanediol
3-allyloxy-propane-1,2-diol
-Allylglyceroether | [EINECS(EC#)]
204-620-4 | [Molecular Formula]
C6H12O3 | [MDL Number]
MFCD00004721 | [Molecular Weight]
132.16 | [MOL File]
123-34-2.mol |
| Chemical Properties | Back Directory | [Appearance]
clear colorless to light yellow viscous liquid | [Melting point ]
-100 °C | [Boiling point ]
142 °C28 mm Hg(lit.) | [density ]
1.068 g/mL at 25 °C(lit.)
| [vapor pressure ]
0.004 hPa (20 °C) | [refractive index ]
n20/D 1.462(lit.)
| [Fp ]
132 °C
| [storage temp. ]
Store below +30°C. | [solubility ]
Completely miscible in water | [form ]
Viscous Liquid | [pka]
13.75±0.20(Predicted) | [color ]
Clear colorless to light yellow | [PH]
6.5-7.5 (1000g/l, H2O, 20℃) | [Water Solubility ]
163.2g/L at 25℃ | [BRN ]
1701144 | [LogP]
0.29 at 23℃ | [CAS DataBase Reference]
123-34-2(CAS DataBase Reference) | [EPA Substance Registry System]
Glycerol 1-allylether (123-34-2) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36:Irritating to the eyes. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [WGK Germany ]
1
| [RTECS ]
TY2700000
| [HS Code ]
29094990 | [Toxicity]
LD50 orally in Rabbit: 5400 mg/kg LD50 dermal Rat 4300 mg/kg |
| Hazard Information | Back Directory | [Chemical Properties]
clear colorless to light yellow viscous liquid | [Uses]
3-Allyloxy-1,2-propanediol is a useful synthetic intermediate. It is used to prepare doxorubicin analogs. It is also used to synhesize poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. | [Synthesis Reference(s)]
Synthetic Communications, 24, p. 1959, 1994 DOI: 10.1080/00397919408010203 |
|
|